All

Cancer registration in China and its role in cancer prevention and control

Posted on by SGW Content
10
Feb

Wenqiang Wei 1, Hongmei Zeng 1, Rongshou Zheng 1, Siwei Zhang 1, Lan An 1, Ru Chen 1, Shaoming Wang 1, Kexin Sun 1, Tomohiro Matsuda 2, Freddie Bray 3, Jie He 4
Affiliations Expand
PMID: 32615118 DOI: 10.1016/S1470-2045(20)30073-5

Abstract

Cancer has become a leading cause of death in China, with an increasing burden of cancer incidence and mortality observed over the past half century. Population-based cancer registries have been operating in China for about 60 years, and, in 2018, their role has expanded to include the formulation and evaluation of national cancer control programmes and the care of patients with cancer. The purpose of this Review is to provide an overview of the key milestones in the development of cancer registration in China, the current status of registry coverage and quality, and a description of the changing cancer profile in China from 1973 to 2015. This Review is a comprehensive and updated review on the development of population-based cancer registries in China over a 60-year time span. We highlight some aspects of cancer control plans that illustrate how cancer registration data have become central to the identification of health priorities for China and provide a means to track progress in cancer control for the country.

PubMed Disclaimer

Similar articles

  • [Report of Cancer Incidence and Mortality in China, 2014].

    Chen WQ, Li H, Sun KX, Zheng RS, Zhang SW, Zeng HM, Zou XN, Gu XY, He J.Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):5-13. doi: 10.3760/cma.j.issn.0253-3766.2018.01.002.PMID: 29365411 Chinese.
  • [Strengthen the cancer surveillance to promote cancer prevention and control in China].

    He J.Zhonghua Zhong Liu Za Zhi. 2018 Jan 23;40(1):1-4. doi: 10.3760/cma.j.issn.0253-3766.2018.01.001.PMID: 29365410 Review. Chinese.

  • The incidence and mortality of major cancers in China, 2012.

    Chen W, Zheng R, Zeng H, Zhang S.Chin J Cancer. 2016 Aug 2;35(1):73. doi: 10.1186/s40880-016-0137-8.PMID: 27484217 Free PMC article.

  • Cancer incidence and mortality in China, 2013.

    Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, Yang Z, Zou X, He J.Cancer Lett. 2017 Aug 10;401:63-71. doi: 10.1016/j.canlet.2017.04.024. Epub 2017 May 3.PMID: 28476483

  • Cancer Registration in India – Current Scenario and Future Perspectives.

    Chatterjee S, Chattopadhyay A, Senapati SN, Samanta DR, Elliott L, Loomis D, Mery L, Panigrahi P.Asian Pac J Cancer Prev. 2016;17(8):3687-96.PMID: 27644602 Review.
See all similar articles

Cited by

  • Clinical characteristics and prognosis of non-high-risk patients with incidental stage T1 lung cancer: A prospective cohort study.

    Peng M, Li W, Dai H, Ao M, Chen J, Liu A, Wang H, Yao S, Yang L.Clin Exp Med. 2024 Aug 21;24(1):195. doi: 10.1007/s10238-024-01459-0.PMID: 39167309 Free PMC article.

  • Cost-effectiveness analysis of adjuvant therapy with atezolizumab in Chinese patients with stage IB-IIIA resectable NSCLC after adjuvant chemotherapy.

    Chen P, Yang Q, Li Y, Jing X, Chen J.Front Oncol. 2022 Sep 5;12:894656. doi: 10.3389/fonc.2022.894656. eCollection 2022.PMID: 36158650 Free PMC article.

  • Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study.

    Feng J, Chen X, Wei J, Weng Y, Wang J, Wang T, Song Q, Min P.Sci Rep. 2024 Jan 28;14(1):2315. doi: 10.1038/s41598-024-52034-2.PMID: 38281979 Free PMC article.

  • Core and bridge symptoms of demoralization in Chinese female cancer patients: a network analysis.

    Gong Y, Shang B, Tan J, Luo C, Bian Z, Wu X, Fan T, Zhao Q, Liu L, Sun W.Front Psychiatry. 2024 Feb 5;15:1273411. doi: 10.3389/fpsyt.2024.1273411. eCollection 2024.PMID: 38374974 Free PMC article.

  • Epidemiological Characteristics of Pancreatic Cancer in China From 1990 to 2019.

    Zhu B, Wu X, Guo T, Guan N, Liu Y.Cancer Control. 2021 Jan-Dec;28:10732748211051536. doi: 10.1177/10732748211051536.PMID: 34713730 Free PMC article.
SGW Content

Leave a Reply

Your email address will not be published. Required fields are marked *